Articles| Volume 333, ISSUE 3, P154-160, March 2007

Download started.


Decreased Hemoglobin Levels Are Associated with Higher Plasma Level of Fibrinogen, Irrespective of Age



      Increased plasma levels of fibrinogen are been associated with an increased risk of cardiovascular accident. We aimed at verifying whether the changes of fibrinogen levels are associated with red blood cell (and/or hemoglobin) concentration.


      A group of 381 carefully selected healthy volunteers (219 male and 162 female), aged from 18 to 101 years, were enrolled in this study. Fasting blood samples were taken and all measurements (fibrinogen plasma level, whole blood viscosity, hemoglobin concentration, hematocrit value, red blood cell and white blood cell count, platelet count, glucose, total cholesterol and triglycerides plasma concentration, and C-reactive protein level) were obtained with standardized methodology using appropriate equipment, procedures, and controls.

      Results and Conclusions

      In the male but not in the female group, plasma fibrinogen concentration inversely correlated with hemoglobin (P < 0.0001) and hematocrit value (P < 0.01). In a post hoc analysis, plasma fibrinogen level inversely correlated with hemoglobin in the subgroup of the 93 premenopausal women and directly correlated with age and inversely correlated with platelet count in the subgroup of the 69 postmenopausal women. Results of multiple regression analysis revealed that in all the subjects, except in the postmenopausal women, hemoglobin level is an independent predictor of fibrinogen plasma level. Considering the physiopathologic role of increased plasma fibrinogen concentration and the scarcity of pharmacologic approaches to decrease its level, these findings could be important in designing a preventive therapy of cardiovascular disease.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meade T.W.
        • Mellows S.
        • Brozovic M.
        • et al.
        Haemostatic function and ischemic heart disease: principal results of the Northwick Park heart study.
        Lancet. 1986; 2: 533-537
        • Ernst E.
        • Resch K.L.
        Fibrinogen as a cardiovascular risk factor: a metanalysis and review of the literature.
        Ann Intern Med. 1993; 118: 956-963
        • Heinrich J.
        • Balleisen L.
        • Schulte W.
        • et al.
        Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
        Arterioscler Thromb. 1994; 14: 54-59
        • Woodward M.
        • Lowe G.D.
        • Rumley A.
        • et al.
        Fibrinogen as risk factor for coronary heart disease and mortality in middle-age men and women. The Scottish Heart Health Study.
        Eur Heart J. 1998; 19: 55-62
        • Ma J.
        • Hennekens C.H.
        • Ridker P.M.
        • et al.
        A prospective study of fibrinogen and risk of myocardial infarction in the Physicians’ Health Study.
        J Am Coll Cardiol. 1999; 33: 1347-1352
        • Maresca G.
        • Di Blasio A.
        • Marchioli R.
        • et al.
        Measuring plasma fibrinogen to predict stroke and myocardial infraction. An update.
        Arterioscler Thromb Vasc Biol. 1999; 19: 1368-1377
        • Bielak L.F.
        • Klee G.G.
        • Sheedy II, P.F.
        • et al.
        Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography.
        Arterioscler Thromb Vasc Biol. 2000; 20: 2167-2171
        • Blake G.
        • Schmitz C.
        • Lindpaintner K.
        • et al.
        Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
        Eur Heart J. 2001; 22: 2262-2266
        • Cantin B.
        • Despres J.P.
        • La marche B.
        • et al.
        Association of fibrinogen and lipoprotein (a) as a coronary heart disease factor in men (The Quebec Cardiovascular Study).
        Am J Cardiol. 2002; 89: 662-666
        • Chien S.
        Haemorheology in disease: pathophysiological significance and therapeutic implications.
        Clin Hemorheol. 1981; 1: 419-442
        • Danesh J.
        • Collins R.
        • Peto R.
        • et al.
        Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease.
        Eur Heart J. 2000; 21: 5151-5520
        • Humphries S.E.
        • Cook M.
        • Dubowitz M.
        • et al.
        Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.
        Lancet. 1987; 1: 1452-1455
        • Iso H.
        • Folsom A.R.
        • Winkelmann J.C.
        Polimorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples.
        Thromb Haemost. 1995; 73: 106-111
        • Margaglione M.
        • Cappucci G.
        • Colaizzo D.
        • et al.
        Fibrinogen plasma level in an apparently healthy general population. Relation to environmental and genetic determinants.
        Thromb Haemost. 1998; 80: 805-810
        • Krobot K.
        • Hense H.W.
        • Cremer P.
        • et al.
        Determinants of plasma fibrinogen: relation to body weight waist to hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989–1990.
        Arterioscler Thromb. 1992; 12: 780-788
        • Halle M.
        • Berg A.
        • Keul J.
        • et al.
        Association between serum fibrinogen concentrations and HDL and LDL lipoprotein subfraction phenotypes in healthy men.
        Arterioscler Thromb Vasc Biol. 1996; 16: 144-148
        • De Pergola G.
        • De Mitrio V.
        • Sciaraffia M.
        • et al.
        Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
        Metabolism. 1997; 46: 1287-1293
        • James S.
        • Vorster H.H.
        • Venter C.S.
        • et al.
        Nutritional status influence plasma fibrinogen concentration: evidence from the THUSA survey.
        Thromb Res. 2000; 98: 383-394
        • Steptoe A.
        • Kunz-Ebrecht S.
        • Owen N.
        • et al.
        Influence of socio-economic status and job control on plasma fibrinogen responses to acute mental stress.
        Psychosom Med. 2003; 65: 137-144
        • Bo M.
        • Raspo S.
        • Morra F.
        • et al.
        Body fat is the main predictor of fibrinogen levels in healthy non-obese men.
        Metabolism. 2004; 53: 984-1008
        • De Maat M.P.M.
        Effects of diet, drugs, and genes on plasma fibrinogen levels.
        Ann NY Acad Sci. 2001; 936: 509-521
        • Coppola L.
        • Caserta F.
        • De Lucia D.
        • et al.
        Blood viscosity and aging.
        Arch Gerontol Geriatr. 2000; 31: 35-42
        • Resnick N.M.
        Geriatric Medicine.
        in: Harrison’s Principles of Internal Medicine. McGraw-Hill, New York1998: 39-46
        • Clauss A.
        Gerinnungs physiologische Schnellmethode zur Bestimmung des Fibrinogens.
        Acta Haematol. 1957; 17: 237-246
        • Laharrague P.F.
        • Cambus J.P.
        • Fillola G.
        • et al.
        Plasma fibrinogen and physiological aging.
        Aging Clin Exper. 1993; 5: 445-449
        • Cavestri R.
        • Radice L.
        • Ferrarini F.
        • et al.
        Influence of erythrocyte aggregability and plasma fibrinogen concentration on CBF with aging.
        Acta Neurol Scand. 1992; 85: 292-298
        • Barasch E.
        • Benderly M.
        • Graff E.
        • et al.
        Plasma fibrinogen levels and their correlate in 6457 coronary heart diseases patients. The Bezafibrate Infarction Prevention (BIF) study.
        J Clin Epidemiol. 1995; 48: 757-765
        • Ko G.T.
        • Yeung V.T.
        • Chan J.C.
        • et al.
        Plasma fibrinogen concentration in a Chinese population.
        Artherosclerosis. 1997; 131: 211-217
        • Maher J.T.
        • Levine P.H.
        • Cymerman A.
        Human coagulation abnormalities during acute exposure to hypobaric hypoxia.
        J Appl Physiol. 1976; 41: 702-707
        • Rupert J.L.
        • Devine D.V.
        • Monsalve M.V.
        • et al.
        Beta-fibrinogen allele frequencies in Peruviam Quechua, a high-altitude native population.
        Am J Phys Antropol. 1999; 109: 181-186
        • Rupert J.L.
        • Monsalve M.V.
        • Kidd K.K.
        • et al.
        Selective pressure has not acted against hypercoagulability alleles in high-altitude Amerindians.
        Ann Hum Genet. 2003; 67: 426-432
        • Mandai R.
        • Eguchi Y.
        • Tanaka M.
        • et al.
        Effects of profound hemodilution on small-intestinal wound healing in rabbits.
        J Surg Res. 2001; 99: 107-113
        • Beguin Y.
        • Loo M.
        • R’Zirk S.
        • et al.
        Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrrin receptor and fibrinogen.
        Blood. 1993; 7: 2010-2016
        • Coppola L.
        • Guastafierro S.
        • Grimaldi R.
        • et al.
        Donazioni di sangue e livelli plasmatici di fibrinogeno.
        Atti Giornate Scientifiche della Seconda Università di Napoli. 2002; : 235-236
        • Breddin H.K.
        • Lippod R.
        • Bittner M.
        • et al.
        Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HARPAG Study. Haemostatic parameters as risk factors in healthy volunteers.
        Atherosclerosis. 1999; 144: 211-219
        • Meade T.W.
        Fibrinogen in ischaemic heart disease.
        Eur Heart J. 1995; 16: 31-34
        • Vazquez-Chavez C.
        • Salinas-Orozco S.
        • Gomez-Diaz R.A.
        • et al.
        Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia.
        Rev Invest Clin. 1998; 50: 491-496
        • Wierzbicki A.S.
        • Lumb P.J.
        • Chik G.
        • et al.
        Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia.
        Am J Cardiol. 2001; : 338-340